Cadrenal Therapeutics, Inc. Dividends Per Share
Cadrenal Therapeutics, Inc. (CVKD) reported Dividends Per Share of $16.50 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2026-03-31
- Cadrenal Therapeutics, Inc. common stock, dividends, per share, declared for the quarter ending 2025-12-31 was $0.00.
- Cadrenal Therapeutics, Inc. common stock, dividends, per share, declared for the quarter ending 2025-09-30 was $0.00.
- Cadrenal Therapeutics, Inc. common stock, dividends, per share, declared for the quarter ending 2025-06-30 was $0.00.
- Cadrenal Therapeutics, Inc. common stock, dividends, per share, declared for the quarter ending 2025-03-31 was $16.50.
- Cadrenal Therapeutics, Inc. common stock, dividends, per share, declared for fiscal 2025 was $16.50, a 0.00% change from fiscal 2024.
- Cadrenal Therapeutics, Inc. common stock, dividends, per share, declared for fiscal 2024 was $16.50.
| Period end | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 6 month | Common Stock, Dividends, Per Share, Declared 9 month | Common Stock, Dividends, Per Share, Declared 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $16.50 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $16.50 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $16.50 10-Q · filed 2025-08-11 | ||
| 2025-03-31 | $16.50 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $16.50 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |